NCT01061645
- Conditions
- Anemia, Anemia, Dyserythropoietic, Congenital, Anemia, Hemolytic, +9 more
- Locations
-
- The Norwegian Radium Hospital, Department of Clinical Cancer Research Oslo, Norway
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
150 public trials
27 recruiting studies
Carcinoma trial results
NCT04033991
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +2 more
- Locations
-
- Pfizer UK London, United Kingdom
NCT01572493
- Conditions
- Carcinoma, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT05593744
- Conditions
- Carcinoma, Neoplasms, Neoplasms by Histologic Type, +1 more
- Locations
-
- Qilu Hospital, Shandong University Jinan, Shandong, China
Completed
Phase 1/2 Study of Ensartinib and Durvalumab, in ALK-rearranged Non-small Cell Lung Cancer
NCT02898116
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
- Locations
-
- Research Facility New York, United States
NCT00446446
- Conditions
- Cancer, Carcinoma, Carcinoma, Squamous Cell, +17 more
- Locations
-
Not specified
NCT03562897
- Conditions
- Adnexal Diseases, Carcinoma, Endocrine Gland Neoplasm, +23 more
- Locations
-
- National Institute of Oncology and Radiobiology (INOR) Havana, Cuba
NCT04419207
- Conditions
- Carcinoma, Lung Cancer, Lung Diseases, +9 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
NCT00152477
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Budapest, Hungary
- Deszk, Hungary
- Mátraháza, Hungary
- Nyíregyháza, Hungary
NCT04008082
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
- Locations
-
- Eisai Trial Site #1 Osaka, Japan
- Eisai Trial Site #2 Tokyo, Japan